Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "NCEs"

2668 News Found

Suven Life Sciences posts Q1FY23 consolidated loss at Rs. 16.32 Cr
News | July 26, 2022

Suven Life Sciences posts Q1FY23 consolidated loss at Rs. 16.32 Cr

Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022


Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr
News | July 26, 2022

Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr

The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.


Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Drug Approval | July 24, 2022

Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market

Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.


Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune
News | July 18, 2022

NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune

ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event


Enveric Biosciences advances drug development for mental health indications
Biotech | July 16, 2022

Enveric Biosciences advances drug development for mental health indications

Advancing to IND-enabling studies with multiple drug candidates


Athos announces research collaboration to advance precision medicine in inflammatory bowel disease
News | July 13, 2022

Athos announces research collaboration to advance precision medicine in inflammatory bowel disease

Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples


Sirio Pharma announces agreement to acquire best formulations
News | July 10, 2022

Sirio Pharma announces agreement to acquire best formulations

The combined company will be able to better serve both our global and regional customers with local production


NHA announces successful onboarding of 1 lakh+ healthcare facilities
Policy | July 07, 2022

NHA announces successful onboarding of 1 lakh+ healthcare facilities

It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers